Results 221 to 230 of about 257,222 (353)

Safety and efficacy of hepaticoduodenostomy for biliary reconstruction after extrahepatic mid-bile duct cancer surgery. [PDF]

Gland Surg
Lee O, Lee C, Yoon SK, Jeong J, Kim HC, Chung JC.   +5 more
europepmc   +1 more source

Laparoscopic pancreaticoduodenectomy with excision of aberrant right hepatic artery after preoperative segmental embolization in mid-bile duct cancer. [PDF]

J Minim Invasive Surg, 2021
Kook Y, Choi M, Park JY, Hwang HK, Lee WJ, Kim MD, Kang CM.   +6 more
europepmc   +1 more source

Highly Reproducible, Vendor‐Agnostic, Motion‐Insensitive Liver PDFF Mapping at 0.55T, 1.5T, and 3T

Magnetic Resonance in Medicine, EarlyView.
ABSTRACT Purpose To develop and validate a vendor‐agnostic, motion‐insensitive proton‐density fat‐fraction (PDFF) quantification method. Methods Flip‐angle‐modulated (FAM) 2D chemical‐shift‐encoded (CSE) MRI for PDFF quantification was implemented in both the vendor‐agnostic platform Pulseq (“Pulseq‐FAM”) and one vendor‐specific platform (“GE‐specific ...
Jiayi Tang, Daiki Tamada, Jon‐Fredrik Nielsen, Jitka Starekova, Julius F. Heidenreich, Felix Schön, Alexandra A. Anagnostopoulos, Amirhossein Roshanshad, Lu Mao, Shohei Fujita, Pengcheng Xu, Christopher Keen, Imam Ahmed Shaik, Eugene Milshteyn, Seonghwan Yee, Andrew J. Ellison, David Rutkowski, Jeff Kammerman, Jean H. Brittain, Xiaodong Zhong, William A. Grissom, Maxim Zaitsev, Aaron L. Carrel, Yogesh Rathi, Yun Jiang, Berkin Bilgic, Scott B. Reeder, Diego Hernando   +27 more
wiley   +1 more source

Prognostic Significance of CD11b-, CD8-, and CD163-Positive Tumor-Infiltrating Immune Cells in Distal Bile Duct Cancer. [PDF]

J Pers Med
Choi JH, Kim JY, Lee KR, Lee GY, Hong M, Hwang HW, Lee MY, Kim MK, Hong SA.   +8 more
europepmc   +1 more source

Therapeutic potential of tetrahydroxylated bile acids in reducing liver injury: Insights from the Zfyve19−/− mouse model

Pediatric Investigation, EarlyView.
THBA (3α,6α,7α,12α‐Tetrahydroxy‐10β,13β‐pentanoic acid) administration can alleviate cholestatic liver injury, hepatocellular necrosis, inflammatory response, bile duct hyperplasia, and portal fibrosis in the Zfyve19−/− mouse model. This evaluation encompasses various parameters, including serum biochemistry, liver histology, immunostaining, and ...
Li Wang, Yue Yu, Jiayan Feng, Yanan Zhang, Renxue Wang, Huiyu She, Teng Liu, Victor Ling, Jianshe Wang   +8 more
wiley   +1 more source

Clinical performance of endoscopic ultrasound-guided tissue acquisition for perivascular soft-tissue cuffing suspected to be extravascular migratory metastases of pancreatic or bile duct cancer (with video). [PDF]

Dig Endosc
Maehara K, Hijioka S, Nagashio Y, Maruki Y, Yamashige D, Okamoto K, Agarie D, Yagi S, Fukuda S, Kuwada M, Komori Y, Koga T, Kanno A, Imamura T, Saito Y, Okusaka T.   +15 more
europepmc   +1 more source

A case of mucin-producing bile duct cancer with difficulty in differentiation from bile duct cystadenocarcinoma

, 2009
Kazumasa Noda, Nobutaka Umekita, Keiichi Nasu, Satoru Inoue, Masahiro Warabi   +4 more
openalex   +2 more sources

Does Sphincteroplasty Predispose to Bile Duct Cancer? [PDF]

, 1999
Russell W. Strong
openalex   +1 more source

Intrahepatic Bile Duct Cancer pT4 TNM Finding v7 [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

Targeted Nanocomplex Delivery for Protecting Vascular Integrity and Enhancing Anticancer Effects in Hepatocellular Carcinoma

Small Science, EarlyView.
Herein, a liver‐targeted nanohybrid formulation, SGLC/DOX@AG, is developed to enhance doxorubicin delivery and reduce vascular toxicity in hepatocellular carcinoma (HCC) treatment. Incorporating an albumin–glucosamine lipid complex, the system shows potent anticancer effects and minimized side effects across in vitro, in vivo, and cancer‐on‐a‐chip ...
Hyelim Kim, Han Sol Lee, June Hong Ahn, Tae‐Wan Kwon, So‐Yeol Yoo, Donghyuk Seo, Sang Kyum Kim, Hee Ho Park, Seung‐Woo Cho, Wonhwa Lee, Jae‐Young Lee, Hong Nam Kim   +11 more
wiley   +1 more source